- September 23, 2022
GLOBAL GENES PODCAST: Global Genes spoke to spoke to Axel Bolte, co-founder and CEO of Inozyme, about ENPP1 deficiency, its lead experimental therapy to treat the condition, and its work with Rady Childrenās Institute for Genomic Medicine to improve the diagnosis of newborns.